Filter
719
Text search:
drug
formulations
Featured
Recommendations
91
New Publications
210
Language
Document type
No document type
399
Guidelines
150
Studies & Reports
94
Manuals
37
Training Material
13
Strategic & Response Plan
10
Fact sheets
9
Situation Updates
2
Resource Platforms
2
Brochures
1
App
1
Infographics
1
Countries / Regions
India
51
Kenya
28
Global
23
Ethiopia
15
South Africa
15
Malawi
15
Western and Central Europe
12
Africa
12
Tanzania
11
Uganda
10
Nepal
10
Bangladesh
10
Sierra Leone
9
Nigeria
8
Zimbabwe
8
Zambia
8
Namibia
8
Liberia
7
Ghana
7
Philippines
7
Rwanda
7
Myanmar / Burma
7
South–East Asia Region
6
Latin America and the Carribbean
6
Eastern Europe
6
Cameroon
4
Cambodia
4
Eswatini/ Swaziland
4
Senegal
3
Haiti
3
Syria
3
Benin
3
Botswana
3
Burkina Faso
2
Indonesia
2
East and Southern Africa
2
Middle East and North Africa
2
Russia
2
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Pakistan
1
South Sudan
1
Afghanistan
1
Thailand
1
Malaysia
1
Mozambique
1
Argentina
1
Peru
1
Brazil
1
Ukraine
1
Colombia
1
Bolivia
1
Madagascar
1
Lesotho
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Venezuela
1
Congo-Brazzaville
1
Tajikistan
1
Australia
1
Georgia
1
North America
1
France
1
Authors & Publishers
Publication Years
Category
Countries
258
Clinical Guidelines
129
Women & Child Health
33
Public Health
32
Key Resources
19
Pharmacy & Technologies
15
Capacity Building
9
Toolboxes
HIV
105
TB
92
Pharmacy
63
AMR
40
Mental Health
32
NTDs
32
COVID-19
15
NCDs
15
Malaria
13
Rapid Response
9
Caregiver
9
Ebola & Marburg
8
Refugee
5
Planetary Health
5
Disability
4
Conflict
4
2.0 Rapid Response
4
Cholera
3
Polio
3
Health Financing Toolbox
3
Zika
2
Specific Hazards
2
Global Health Education
2
Pharmaceuticals 2024, 17(6), 691; https://doi.org/10.3390/ph17060691
Published: 5 January 2010 Received: 30 January 2009
BMC Neurology 2010, 10:1 doi:10.1186/1471-2377-10-1
This article is available from: http://www.biomedcentral.com/1471-2377/10/1
Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been documented in many South American, Asian, and Western Pacific countries and is widespread throughout much of Africa, especially in West
...
Rwanda Guidelines for variation to registered pharmaceutical products.
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines
...
Draft for consultation
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
Accessed at March 2014
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.